Aboubakar et al. could show that the expression of both total FAK and activated FAK was significantly higher in lung cancer compared to normal lung tissue and was significantly higher in small-cell lung cancer compared to non-small-cell lung cancer. This evidence concerns the gene PTK2 and lung carcinoma.